MetaCap

Gossamer Bio Insider Trades

NASDAQ: GOSSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

10.72-0.51 (-4.54%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Gossamer Bio insider activity

Over the last 12 months, Gossamer Bio insiders reported 6 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Smith Robert Paul JR (Chief Commercial Officer) reporting a transaction in 93,750 shares on Jan 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put GOSS's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

GOSS insider transactions

Gossamer Bio insider transactions
DateInsiderTypeSharesValueFiling
Jan 2, 2026Christian WaageEVP, Tech Ops and AdminAward84,500—Form 4
Jan 2, 2026Peterson CarynEVP, Regulatory AffairsAward84,500—Form 4
Jan 2, 2026Aranda RichardChief Medical OfficerAward93,750—Form 4
Jan 2, 2026Giraudo BryanCOO/CFOAward115,750—Form 4
Jan 2, 2026Hasnain FaheemPresident & CEOAward280,000—Form 4
Jan 2, 2026Smith Robert Paul JRChief Commercial OfficerAward93,750—Form 4
Oct 1, 2025Peterson CarynEVP, Regulatory AffairsAward125,000—Form 4
Oct 1, 2025Giraudo BryanCOO/CFOAward181,250—Form 4
Oct 1, 2025Christian WaageEVP, Tech Ops and AdminAward125,000—Form 4
Oct 1, 2025Hasnain FaheemPresident & CEOAward437,500—Form 4
Oct 1, 2025Aranda RichardChief Medical OfficerAward162,500—Form 4
Oct 1, 2025Smith Robert Paul JRChief Commercial OfficerAward162,500—Form 4
Aug 19, 2025Milligan SandraDirectorBuy26,050$50.02KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related